Extended Table 2a.
Any-Grade AE n (%) | 0.7 mg | 2 mg | 7.0 mg | 10 mg |
---|---|---|---|---|
N | 3 | 3 | 3 | 3 |
Fever* | 0 | 0 | 3 | 2 |
Pain | 1 | 2 | 2 | 0 |
Rigor/Chills* | 0 | 0 | 1 | 2 |
Injection site reaction* | 0 | 1 | 2 | 0 |
Infection | 0 | 2 | 0 | 1 |
Fatigue | 0 | 1 | 1 | 0 |
MyalgiasΦ | 0 | 1 | 1 | 0 |
Dyspnea | 0 | 0 | 1 | 1 |
Anemia | 0 | 0 | 2 | 0 |
RashΦ | 0 | 0 | 1 | 0 |
Nausea | 1 | 0 | 0 | 0 |
Hot flashesΦ | 0 | 1 | 0 | 0 |
Dysphagia | 0 | 1 | 0 | 0 |
Sinus bradycardia | 0 | 0 | 1 | 0 |
Depression | 0 | 0 | 1 | 0 |
Treatment related adverse event
Possibly related to 2141-V11